Paper · 38006346

Modulation of semaphorin 3C & 4D expression in cancerous tissues from individuals with laryngeal squamous cell carcinoma.

Sajadian M and 5 others. Indian J Med Res, 2023. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Modulation of semaphorin 3C & 4D expression in cancerous tissues from individuals with laryngeal squamous cell carcinoma. Papers, record 38006346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38006346

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Modulation of semaphorin 3C & 4D expression in cancerous tissues from individuals with laryngeal squamous cell carcinoma.; PubMed
Journal: Indian J Med Res; PubMed
Year: 2023; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/38006346/; PubMed
DOI: https://doi.org/10.4103/ijmr.ijmr_3148_21; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC10793821/; PubMed
The journal: https://conductscience.org/library/journal-index/0374701; PubMed
Citations, by iCite: 0; iCite
Relative citation ratio, by iCite: 0; iCite
Revised in PubMed: 2025-11-14; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Sajadian M	Marzieh
2	Khademi B	Bijan
3	Moinzadeh L	Leila
4	Ghaderi A	Abbas
5	Jafarzadeh A	Abdollah
6	Razmkhah M	Mahboobeh

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Semaphorins	Major topic
Head and Neck Neoplasms	Major topic
Humans
Semaphorin-3A
Vascular Endothelial Growth Factor A
Squamous Cell Carcinoma of Head and Neck

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	35,785,187	SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment.	Front Oncol	2022	https://conductscience.org/library/papers/35785187	PubMed
2	31,603,112	Expression of major histocompatibility complex class I polypeptide-related sequence B in adipose-derived stem cells from breast cancer patients and normal individuals.	J Cancer Res Ther	2019	https://conductscience.org/library/papers/31603112	PubMed
3	28,635,679	The Role of Angiogenesis in Cancer Treatment.	Biomedicines	2017	https://conductscience.org/library/papers/28635679	PubMed
4	27,912,840	The semaphorins and their receptors as modulators of tumor progression.	Drug Resist Updat	2016	https://conductscience.org/library/papers/27912840	PubMed
5	12,406,905	CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.	Blood	2003	https://conductscience.org/library/papers/12406905	PubMed
6	28,315,433	Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.	Cancer Lett	2017	https://conductscience.org/library/papers/28315433	PubMed
7	35,071,491	A deep convolutional neural network-based method for laryngeal squamous cell carcinoma diagnosis.	Ann Transl Med	2021	https://conductscience.org/library/papers/35071491	PubMed
8	29,450,692	Expression of semaphorin class 3 is higher in the proliferative phase on the human endometrium.	Arch Gynecol Obstet	2018	https://conductscience.org/library/papers/29450692	PubMed
9	32,210,960	Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?	Front Immunol	2020	https://conductscience.org/library/papers/32210960	PubMed
10	22,508,695	Anti-VEGF/VEGFR therapy for cancer: reassessing the target.	Cancer Res	2012	https://conductscience.org/library/papers/22508695	PubMed

1 to 10 of 34

See all 34 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
EIF2AK3	9,451	PubTator's text mining	https://conductscience.org/library/genes/9451	NCBI Gene
FLT1	2,321	PubTator's text mining	https://conductscience.org/library/genes/2321	NCBI Gene
FOXO3	2,309	PubTator's text mining	https://conductscience.org/library/genes/2309	NCBI Gene
IL12B	3,593	PubTator's text mining	https://conductscience.org/library/genes/3593	NCBI Gene
KDR	3,791	PubTator's text mining	https://conductscience.org/library/genes/3791	NCBI Gene
LGALS3	3,958	PubTator's text mining	https://conductscience.org/library/genes/3958	NCBI Gene
NRP1	8,829	PubTator's text mining	https://conductscience.org/library/genes/8829	NCBI Gene
NRP2	8,828	PubTator's text mining	https://conductscience.org/library/genes/8828	NCBI Gene
POTEF	728,378	PubTator's text mining	https://conductscience.org/library/genes/728378	NCBI Gene
PTEN	5,728	PubTator's text mining	https://conductscience.org/library/genes/5728	NCBI Gene

1 to 10 of 20

See all 20 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38006346

GET https://conductscience.org/api/papers/v1/38006346/references?page=2

API reference For AI assistants